← Browse by Condition
Medical Condition
clear cell renal cell carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Enrollment
362 pts
Location
United States, Austr...
Sponsor
Arcus Biosciences, Inc.
NCT07389629 Phase 2
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Enrollment
25 pts
Location
China
Sponsor
Sun Yat-sen University